CROs Poised to Benefit From Biopharma Outsourcing
January 11, 2019 at 07:00 AM EST
Of the contract research organizations we cover, Syneos looks most attractively valued.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|